Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of BIA 2-093 in Healthy Elderly vs Young Subjects
NCT02172755Phase 1Completed
- Sponsor
- BIAL
- Start
- Jun 2002
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of eslicarbazepine acetate in epilepsy (2 arms), sponsored by BIAL. Primary endpoint: Maximum Drug Concentration at Day 12. Started Jun 2002; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02172755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172755.